Home > Insider Trading > Filing (0001209191-15-047221)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1516479	Insys Therapeutics Inc.	INSY	Pharmaceutical Preparations (2834)	510327886

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1467848	Brian Tambi	C/O Insys Therapeutics, Inc. 444 South Ellis Street Chandler AZ 85224		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-05-26	1,800	$1.22	1,800	No	4	M	Direct
Common Stock	Disposition	2015-05-26	1,800	$60.00	0	No	4	S	Direct
Common Stock	Acquisiton	2015-05-27	3,100	$1.22	3,100	No	4	M	Direct
Common Stock	Disposition	2015-05-27	3,100	$60.09	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2015-05-26	1,800	$0.00	1,800	$1.22
Common Stock	Stock Option (right to buy)	Disposition	2015-05-27	3,100	$0.00	3,100	$1.22

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
19,927		2020-02-21	No	4	M	Direct
16,827		2020-02-21	No	4	M	Direct

Footnotes

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.44 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option is fully vested and exercisable.